Janney Montgomery Scott
AMRX icon

Janney Montgomery Scott’s Amneal Pharmaceuticals AMRX Stock Holding History

Janney Montgomery Scott’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$340K Sell
27,369
-3,258
-11% -$43.7K ﹤0.01% 2299
2025
Q4 		$386K Buy
30,627
+7,477
+32% +$85.5K ﹤0.01% 2383
2025
Q3 		$232K Hold
23,150
– – ﹤0.01% 2647
2025
Q2 		$187K Buy
23,150
+3,800
+20% +$28.6K ﹤0.01% 2579
2025
Q1 		$162K Buy
19,350
+4,100
+27% +$34.2K ﹤0.01% 2560
2024
Q4 		$121K Buy
+15,250
New +$128K ﹤0.01% 2612
2024
Q3 		– Sell
-11,960
Closed -$76K – 2655
2024
Q2 		$76K Buy
+11,960
New +$75.9K ﹤0.01% 2542

Other funds holding AMRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return